🇺🇸 Measles vaccine in United States
34 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 34
Most-reported reactions
- Drug Hypersensitivity — 5 reports (14.71%)
- Drug Intolerance — 5 reports (14.71%)
- Febrile Neutropenia — 5 reports (14.71%)
- Gastrointestinal Disorder — 5 reports (14.71%)
- Varicella Zoster Virus Infection — 4 reports (11.76%)
- Anuria — 2 reports (5.88%)
- Encephalopathy — 2 reports (5.88%)
- Febrile Convulsion — 2 reports (5.88%)
- Granuloma — 2 reports (5.88%)
- Influenza — 2 reports (5.88%)
Other Immunology / Infectious Disease approved in United States
Frequently asked questions
Is Measles vaccine approved in United States?
Measles vaccine does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Measles vaccine in United States?
Bandim Health Project is the originator. The local marketing authorisation holder may differ — check the official source linked above.